Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Chris Winfrey, MD

Articles by Chris Winfrey, MD

Trending on Psychiatric Times

The Social Challenge of the Powerful Taking Care of the Poor: Columbus Day, Indigenous People’s Day, and More

Asynchronous ADHD Assessment: New Tools for Better Evaluation

Women Are Diagnosed With ADHD 5 Years Later Than Men

Early Dose Management and Up-Titration of Esketamine: ECNP Poster Data

Seltorexant Well-Tolerated in Adolescents as an Adjunct Treatment for Major Depressive Disorder

© 2025 MJH Life Sciences^®

All rights reserved.